Skip to main content
. 2025 Aug 6;71(1):138–154. doi: 10.1007/s10620-025-09278-3

Table 2.

Patients with social barriers to completing the HCC–LT pathway

No social barriers (N = 366) Social barriers (N = 129) Total (N = 495) p value
Age at Referral 0.013*
 Mean (SD) 62.4 (7.3) 59.4 (9.5) 61.6 (8.0)
 Median (Q1, Q3) 63.0 (58.0, 67.0) 61.0 (56.0, 66.0) 62.0 (58.0, 67.0)
 Range 23.0–84.0 22.0–73.0 22.0–84.0
Gender 0.701
 Women 93 (25.4%) 35 (27.1%) 128 (25.9%)
 Men 273 (74.6%) 94 (72.9%) 367 (74.1%)
Race 0.141a
 American Indian/Alaskan Native 1 (0.3%) 1 (0.8%) 2 (0.4%)
 Asian 9 (2.5%) 5 (3.9%) 14 (2.8%)
 Black/African American 27 (7.4%) 16 (12.4%) 43 (8.7%)
 Native Hawaiian/Pacific Islander 2 (0.5%) 1 (0.8%) 3 (0.6%)
 White 301 (82.2%) 99 (76.7%) 400 (80.8%)
 Other 1 (0.3%) 0 (0.0%) 1 (0.2%)
 Unknown 25 (6.8%) 7 (5.4%) 32 (6.5%)
Ethnicity 0.718
 Hispanic or Latino 15 (4.1%) 5 (3.9%) 20 (4.0%)
 Non-Hispanic 330 (90.2%) 114 (88.4%) 444 (89.7%)
 Unknown 21 (5.7%) 10 (7.8%) 31 (6.3%)
Marital status 0.034a*
 Married 207 (56.6%) 58 (45.0%) 265 (53.5%)
 Not Married 62 (16.9%) 29 (22.5%) 91 (18.4%)
 Separated 52 (14.2%) 22 (17.1%) 74 (14.9%)
 Widowed 22 (6.0%) 9 (7.0%) 31 (6.3%)
 Unknown 23 (6.3%) 11 (8.5%) 34 (6.9%)
Insurance 0.970a
 Medicaid 210 (57.4%) 73 (56.6%) 283 (57.2%)
 Private 145 (39.6%) 51 (39.5%) 196 (39.6%)
 VA 2 (0.5%) 1 (0.8%) 3 (0.6%)
 Uninsured 6 (1.6%) 3 (2.3%) 9 (1.8%)
 Other 2 (0.5%) 1 (0.8%) 3 (0.6%)
 Unknown 1 (0.3%) 0 (0.0%) 1 (0.2%)
ADI 0.071
 Mean (SD) 68.1 (21.2) 71.7 (20.8) 69.0 (21.1)
 Median (Q1, Q3) 71.0 (55.0, 86.0) 75.0 (59.8, 88.0) 72.0 (56.0, 86.0)
 Range 8.0–100.0 10.0–99.0 8.0–100.0
 N-Miss 4 1 5
ADI Quartile 0.092
 Q1 98 (27.1%) 29 (22.7%) 127 (25.9%)
 Q2 96 (26.5%) 28 (21.9%) 124 (25.3%)
 Q3 92 (25.4%) 38 (29.7%) 130 (26.5%)
 Q4 76 (21.0%) 33 (25.8%) 109 (22.2%)
 N-Miss 4 1 5
Etiology 0.060a
 Alcohol 123 (33.6%) 50 (38.8%) 173 (34.9%)
 MASH 89 (24.3%) 19 (14.7%) 108 (21.8%)
 HCV 110 (30.1%) 46 (35.7%) 156 (31.5%)
 AIH 4 (1.1%) 1 (0.8%) 5 (1.0%)
 Cholestatic (PBC/PSC) 6 (1.6%) 0 (0.0%) 6 (1.2%)
 HBV 11 (3.0%) 4 (3.1%) 15 (3.0%)
 Other 10 (2.7%) 6 (4.7%) 16 (3.2%)
 Unknown 13 (3.6%) 3 (2.3%) 16 (3.2%)
Milan 0.596
 No 84 (23.0%) 34 (26.4%) 118 (23.8%)
 Yes 274 (74.9%) 91 (70.5%) 365 (73.7%)
 Unknown 8 (2.2%) 4 (3.1%) 12 (2.4%)
BCLC 0.830
 0 14 (4.0%) 1 (0.8%) 15 (3.2%)
 A 209 (59.7%) 79 (66.9%) 288 (61.5%)
 B 72 (20.6%) 22 (18.6%) 94 (20.1%)
 C 16 (4.6%) 2 (1.7%) 18 (3.8%)
 D 39 (11.1%) 14 (11.9%) 53 (11.3%)
 N-Miss 16 11 27
MELD-Na 0.035*
 Mean (SD) 12.3 (5.6) 11.1 (4.9) 12.0 (5.4)
 Median (Q1, Q3) 11.0 (8.0, 16.0) 9.0 (8.0, 12.0) 10.0 (8.0, 15.0)
 Range 6.0–32.0 6.0–29.0 6.0–32.0
 N-Miss 15 10 25
BMI 0.770
 Mean (SD) 11.8 (4.9) 10.7 (4.5) 11.5 (4.8)
 Median (Q1, Q3) 11.0 (8.0, 15.0) 9.0 (8.0, 12.0) 10.0 (8.0, 14.0)
 Range 6.0–30.0 6.0–30.0 6.0–30.0
 N-Miss 13 8 21
AFP at Referral 0.175
 Mean (SD) 758.4 (6038.3) 653.8 (4730.1) 730.9 (5718.3)
 Median (Q1, Q3) 7.1 (3.8, 40.2) 6.5 (3.8, 16.4) 7.0 (3.8, 31.0)
 Range 0.9–99,209.0 0.7–49,886.0 0.7–99,209.0
 N-Miss 41 13 54

*p < 0.05

Black vs. White vs. All Other

Married vs. Not Married

Private vs. All Other

Alcohol vs. MASH vs. HCV